Colorectal Neoplasm
62
2
7
30
Key Insights
Highlights
Success Rate
77% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
14.5%
9 terminated out of 62 trials
76.9%
-9.6% vs benchmark
8%
5 trials in Phase 3/4
23%
7 of 30 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 30 completed trials
Clinical Trials (62)
Safety and Efficacy of Reduced-port Laparoscopic Surgery for Patients Of Colon and Upper Rectal Cancer
Decision Aid Website in Helping to Make Decisions About Fertility in Participants With Cancer
Testing a Combination of Vaccines for Cancer Prevention in Lynch Syndrome
Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases
An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Cancer of the Colon or Rectum That Has Spread
ESD for Colorectal LSL Using a Selective Strategy - a Prospective Cohort Study
Enhancing Prevention Pathways Toward Tribal Colorectal Health
Colorectal Cancer Screening in Average-risk Population: Immunochemical Fecal Occult Blood Testing Versus Colonoscopy
Prevalence and Spectrum of Cancer Susceptibility Among Patients with Advanced Colorectal Polyps
Infrapyloric and Greater Curvature Lymph Node Metastasis in Colon Cancer
Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma
Can Malnutrition be Prevented in Patient With Colorectal Cancer Stage Dukes D?
Metastatic Colorectal Cancer: Treatment Response With Dynamic Contrast MRI
Study of TG6002 (VV TK-RR-FCU1) in Combination With 5-FC in Patients With Advanced Gastro-intestinal Tumors.
Study of ASN003 in Subjects With Advanced Solid Tumors
Evaluating the Safety and Effectiveness of the Flex Robotic System for the Surgical Removal of Colorectal Lesions
Fruquitinib Combined With Camrelizumab in Non MSI-H/dMMR Refractory Colorectal Cancer
A Stool DNA Test for Detection of Advanced Colorectal Neoplasia in Asymptomatic Chinese Community Population
Randomized Trial of Primary Surgery Followed Selective Radiochemotherapy for Rectal Cancer With MRI Negative CRM
Phase 1 Trial To Evaluate mFOLFOX6 With Selinexor In Patients With Metastatic Colorectal Cancer